Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology

The purpose of this clinical study is to conduct a multi-center, big data study to create a neural network decision model for predicting treatment efficacy and prognosis based on multi-modal, multi-temporal imaging features combined with tumor microenvironment scores. It will also use various model interpretation techniques to clarify the role and mechanism of key biomarkers or strongly associated biomarker groups in treatment efficacy and prognosis. Ultimately, it aims to achieve the research and application of AI treatment strategies combining multi-modal imaging and digital pathology to guide clinicians in the personalized treatment strategies for patients with esophageal squamous cell carcinoma.

NCT Number	NCT07203690
Lead Sponsor	Henan Cancer Hospital Collaborators: Xinyang Central Hospital, Guangdong Provincial People's Hospital
Conditions	Esophageal Cancer, Neoadjuvant Therapy
Enrollment	7,000 participants
Start Date	2025-12-01
Primary Completion	2027-01-31 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-10-02